BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7634285)

  • 1. [Physiopathologic and clinical features of hypertensive cardiopathy].
    Mancia G; Grassi G
    Cardiologia; 1994 Dec; 39(12 Suppl 1):291-4. PubMed ID: 7634285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hypertension, left ventricular hypertrophy and heart failure].
    Mancia G; Giannattasio C; Grassi G
    Ann Ital Med Int; 1993 Oct; 8 Suppl():5S-8S. PubMed ID: 8117522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antihypertensive treatment and left ventricular hypertrophy].
    Agabiti-Rosei E; Muiesan ML; Rizzoni D
    Ann Ital Med Int; 1993 Oct; 8 Suppl():97S-103S. PubMed ID: 8117529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The primary and secondary prevention of hypertensive cardiopathy].
    Agabiti-Rosei E; Muiesan ML
    Ital Heart J; 2000 Jun; 1 Suppl 2():59-66. PubMed ID: 10905130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypertensive heart disease.
    Diamond JA; Phillips RA
    Hypertens Res; 2005 Mar; 28(3):191-202. PubMed ID: 16097361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Ventricular arrhythmia and sudden cardiac death: the significance of left ventricular hypertrophy as risk factor].
    Schmieder RE; Messerli FH
    Schweiz Med Wochenschr; 1993 Jan; 123(4):99-107. PubMed ID: 7678943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Left bundle branch block and cardiovascular morbidity and mortality in hypertensive patients with left ventricular hypertrophy: the Losartan Intervention For Endpoint Reduction in Hypertension study.
    Li Z; Dahlöf B; Okin PM; Kjeldsen SE; Wachtell K; Ibsen H; Nieminen MS; Jern S; Devereux RB
    J Hypertens; 2008 Jun; 26(6):1244-9. PubMed ID: 18475164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hypertrophy of the left ventricle--etiopathogenesis, clinical consequences and prognosis].
    Ghanem Wisam MA; Murín J; Bulas J
    Vnitr Lek; 1999 Jul; 45(7):421-8. PubMed ID: 11045162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypertension and the heart.
    Mancia G; Scopelliti F; Grassi G
    Semin Cardiothorac Vasc Anesth; 2006 Sep; 10(3):198-202. PubMed ID: 16959750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Left ventricular hypertrophy and geometric remodeling in hypertension: stimuli, functional consequences and prognostic implications.
    Devereux RB; de Simone G; Ganau A; Roman MJ
    J Hypertens Suppl; 1994 Dec; 12(10):S117-27. PubMed ID: 7769482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regression of electrocardiographic left ventricular hypertrophy during antihypertensive therapy and reduction in sudden cardiac death: the LIFE Study.
    Wachtell K; Okin PM; Olsen MH; Dahlöf B; Devereux RB; Ibsen H; Kjeldsen SE; Lindholm LH; Nieminen MS; Thygesen K
    Circulation; 2007 Aug; 116(7):700-5. PubMed ID: 17664372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of angiotensin II blockade on cardiac hypertrophy and remodelling: a review.
    Dahlöf B
    J Hum Hypertens; 1995 Nov; 9 Suppl 5():S37-44. PubMed ID: 8583480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of changes in the electrocardiographic strain pattern during antihypertensive treatment: the Losartan Intervention for End-Point Reduction in Hypertension Study (LIFE).
    Okin PM; Oikarinen L; Viitasalo M; Toivonen L; Kjeldsen SE; Nieminen MS; Edelman JM; Dahlöf B; Devereux RB;
    Circulation; 2009 Apr; 119(14):1883-91. PubMed ID: 19332468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Benefits and risks of hypertension therapy from the cardiac viewpoint].
    Motz W; Strauer BE
    Z Kardiol; 1994 Mar; 83(3):179-87. PubMed ID: 8178541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From left ventricular hypertrophy to congestive heart failure: management of hypertensive heart disease.
    Gradman AH; Alfayoumi F
    Prog Cardiovasc Dis; 2006; 48(5):326-41. PubMed ID: 16627048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Left ventricular hypertrophy: how to influence an important risk factor in hypertension.
    Agabiti-Rosei E; Muiesan ML
    J Hypertens Suppl; 1998 Jan; 16(1):S53-8. PubMed ID: 9534098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypertensive left ventricular hypertrophy risk: beyond adaptive cardiomyocytic hypertrophy.
    Frohlich ED; González A; Díez J
    J Hypertens; 2011 Jan; 29(1):17-26. PubMed ID: 21045723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Left ventricular hypertrophy and heart failure in women.
    Agabiti-Rosei E; Muiesan ML
    J Hypertens Suppl; 2002 May; 20(2):S34-8. PubMed ID: 12183849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hypertensive cardiopathy. From arterial hypertension to congestive heart failure].
    Nogueira JB
    Rev Port Cardiol; 1999 Jun; 18(6):635-46. PubMed ID: 10422461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Impact of arterial hypertension on the heart].
    Herpin D
    Rev Prat; 1999 Mar; 49(5):491-4. PubMed ID: 10358398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.